Opinion Columns & Blogs

Syndicated Columnists

Alzheimer’s drug offers a bit of hope, but it’s no cure

In the most recent clinical trial of Biogen’s experimental drug aducanumab, 165 participants were given varying doses of the drug or a placebo. Brain scans revealed that those taking the drug had a marked reduction in amyloid plaque — a deposit associated with Alzheimer’s disease. There’s little evidence the drug can reverse dementia, but there’s reason to believe something like it might ward off Alzheimer’s disease in healthy people.

Midwest Voices

Social media often lacks thoughtfulness

I experienced my first criticism on social media not long ago. It probably hasn’t happened before because my posts are usually garden-related — green heads of lettuce and giant sweet potatoes, which as far as I can figure, aren’t offensive (whether people care, of course, is another story).

Videos

Silently slamming Sam Brownback on misleading jobs claims: Part II

Gov. Sam Brownback gets the silent treatment — again — for more of his misleading claims about the Kansas jobs market. It's among the worst in America, columnist Yael T. Abouhalkah notes.
Yael T. Abouhalkah The Kansas City Star
Silently slamming Sam Brownback on misleading jobs claims: Part II 1:17

Silently slamming Sam Brownback on misleading jobs claims: Part II

Yael T. Abouhalkah says Donald Trump could surprise a lot more people this fall 1:01

Yael T. Abouhalkah says Donald Trump could surprise a lot more people this fall

Yael T. Abouhalkah has an order: Visit the Kansas City Zoo 0:47

Yael T. Abouhalkah has an order: Visit the Kansas City Zoo

Yael Abouhalkah: Kansas kids are more important than reckless tax cuts 1:26

Yael Abouhalkah: Kansas kids are more important than reckless tax cuts